Cancer Research UK logo.
SearchDonate
  • Search

A trial of lenalidomide and rituximab with or without bendamustine for follicular lymphoma (ReBEL)

Overview

Cancer types:

Blood cancers, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)

Status:

Closed

Phase:

Phase 2

Details

This trial is for people with a type of non Hodgkin lymphoma called follicular lymphoma that has come back after treatment (relapsed).

Cancer Research UK supports this trial.

Recruitment start: 25 November 2016

Recruitment end: 29 March 2019

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Kim Linton

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Other information

This is Cancer Research UK trial number CRUK/12/019.

Last reviewed: 16 Nov 2023

CRUK internal database number: 9539

Help and support